DMP.DE - Dermapharm Holding SE Stock Price & Dividend Safety Sector: Healthcare | Exchange: Deutsche Borse Current Price & Safety Score Price: 38.40 EUR StockBonds Safety Grade: B Altman Z-Score (Bankruptcy Risk): 1.99 StockBond Score: -1.31 Company Description Dermapharm Holding SE alongside its group companies specializes in the offpatent branded pharmaceutical market serving both German and international clients The companys operations are organized into three primary divisions Branded Pharmaceuticals and Other Healthcare Products Parallel Import Business and Herbal Extracts It undertakes the development manufacturing licensing marketing and sale of branded generic medicines overthecounter remedies nonprescription natural health solutions and various other healthcare items Dermapharms product range covers areas such as vitamins minerals nutritional supplements dermatology allergology pain and inflammation management cardiovascular support gynecology and urology prominently featuring brands like Dekristol Dekristolvit Allergovit and Tromcardin Additionally the company provides medical devices including bite away and Herpotherm as well as specific pharmaceutical preparations like Momekort a nasal spray for allergy symptoms and Azedil which functions as a nasal spray or eye drop It also manages the importation of originator pharmaceuticals under the axicorp brand Furthermore Dermapharm supplies herbal extracts and natural active ingredients for application in phytopharmaceuticals nutraceuticals and cosmetics Its clientele encompasses pharmaceutical wholesalers retail pharmacies hospitals and health food stores Founded in 1991 and headquartered in Grunwald Germany Dermapharm Holding SE is a subsidiary of Themis BeteiligungsAktiengesellschaft